MultiCASE Inc. is a pioneer in developing computer programs for assessing toxicological and pharmacological potential of chemicals and pharmaceuticals. Research and development is central to us in developing innovative QSAR methodologies and software solutions. The company has maintained strong academic ties in the areas of computational, medicinal, and environmental chemistry.
MultiCASE Inc. is a USA-based company founded in 1996 by Dr. Gilles Klopman, then a professor of theoretical chemistry at Case Western Reserve University, Cleveland.
Their products include CASE Ultra
expert system for toxicity and bio-activity prediction and Meta-PC
for metabolite structure prediction.
Their customers are regulatory and government agencies, pharmaceutical companies from all over the world, chemical companies, academic institutions and non-profit organizations. They have a history of collaborative research with US FDA CDER
, and other regulatory agencies.